Showing results (371-380 of 541) with videos related to
Sort By:
Pageof 55
Liver Cancer|October 22, 2024
Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion SurgeryZhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, et al.Liver Cancer|May 29, 2026
ErratumLiver Cancer|May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular CarcinomaAnthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.Liver Cancer|May 15, 2026
Hepatic Artery Infusion Chemotherapy for Cholangiocarcinoma in 2025Qi-Feng Chen, Yue Hu, Song Chen, et al.Liver Cancer|April 20, 2026
Age-Adjusted Charlson Comorbidity Index Guides Risk Stratification for Hepatocellular Carcinoma Patients Treated with TACE Combined with Immune Checkpoint Inhibitors and Targeted Therapy: A Multicenter Retrospective Cohort StudyXiaohan Lin, Shiying Zhang, Meiching Ong, et al.Liver Cancer|June 3, 2026
Real-World Comparison of First-Line Atezolizumab plus Bevacizumab and Durvalumab plus Tremelimumab for Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, et al.Liver Cancer|June 16, 2023
PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver CancerSandra Bufe, Artur Zimmermann, Sarina Ravens, et al.Liver Cancer|June 16, 2023
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab TreatmentShunichi Hosoda, Goki Suda, Takuya Sho, et al.Liver Cancer|March 19, 2026
Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic TreatmentsJaejun Lee, Hyun Yang, Si Hyun Bae, et al.Liver Cancer|May 7, 2026
Low Tumor Burden Predicts Benefit from Transarterial Treatment in Hepatocellular Carcinoma with Extrahepatic Metastasis: A Nationwide Cohort StudyJaejun Lee, Hyun Yang, Keungmo Yang, et al.Pageof 55